A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
Yixin Liu(Shanghai Jiao Tong University), Lishuang Qi(Harbin Medical University), Yunyan Gu(Harbin Medical University), Sainan Zhang(Wenzhou Medical University), Zheng Guo(Harbin Medical University), Zheyang Zhang(Harbin Medical University), Ying Li(Shenyang Medical College), Tianhao Li(Tianjin First Center Hospital), Xin Li(Harbin Medical University), Wenyuan Zhao(Jiangxi University of Science and Technology)
Cited by 6
Related Papers
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
|Molecular Cancer|2018|384
Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer
|Carcinogenesis|2010|69
Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway
|Cancer Cell International|2020|55
An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
|British Journal of Cancer|2016|50
An individualized gene expression signature for prediction of lung adenocarcinoma metastases
|Molecular Oncology|2017|47